The price of many pharmaceutical ingredients has spiked for Indian drugmakers following panic buying and Chinese raw material shortages caused by the coronavirus lockdown.
在恐慌性購買和防控冠狀病毒疫情的努力導致中國原料短缺之后,印度制藥商的許多原料藥價格飆升。
您已閱讀5%(216字),剩余95%(4145字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。